Status:
UNKNOWN
ICG Indocyanine Green in Reconstructive Surgery
Lead Sponsor:
Amsterdam UMC, location VUmc
Conditions:
Surgery
Fluorescence
Eligibility:
All Genders
18-110 years
Brief Summary
The success or failure of a reconstruction is largely related to the vascularization of the operated area. Near infrared fluorescence (also near infrared fluorescence angiography, NIR FA) with ICG adm...
Eligibility Criteria
Inclusion
- Aged 18 or older
- Undergoing debridement and/or reconstructive surgery included in the aforementioned groups
Exclusion
- allergy or hypersensitivity to sodium iodide, iodine, ICG or shellfish
- patients with hyperthyroidism and patients with autonomic thyroid adenoma
- pregnancy or lactation
- epilepsy
- severe liver failure
- renal failure with a GFR \<60.
Key Trial Info
Start Date :
May 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06129669
Start Date
May 9 2023
End Date
May 1 2025
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC
Amsterdam, Netherlands